Hypothesis

Telomeres function as quantum coherent sensors that monitor cellular informational entropy through the stability of G‑quadruplex structures; when entropy exceeds a threshold set by mitochondrial ROS‑driven oxidation, G‑quadruplex coherence collapses, triggering subtelomeric epigenetic remodeling and senescence independent of replication count.

Mechanistic Basis

• G‑quadruplexes in telomeric repeats bind K⁺ or Na⁺ with ion‑dependent stereochemistry that supports transient quantum coherence states detectable by circular dichroism and NMR [G-quadruplex ion-dependent stability].
• Oxidative stress generates ROS that lesion guanine bases, destabilizing G‑quadruplexes and increasing local entropic disorder [Oxidative damage accelerates telomere attrition].
• Loss of coherence alters the free‑energy landscape of telomeric chromatin, permitting shifts in subtelomeric DNA methylation and gene expression (TPE‑OLD) without requiring telomere shortening [Telomere length as an epigenetic trait].
• Entropy‑driven coherence loss activates ATM/ATR signaling pathways that enforce G₁ arrest, linking informational overload to cell‑cycle checkpoint activation [Entropy thresholds and transpositional states].

Testable Predictions

1. Pharmacological stabilization of telomeric G‑quadruplexes (e.g., with pyridostatin) will preserve coherence markers and attenuate ROS‑induced subtelomeric methylation changes in non‑dividing fibroblasts.
2. Inducing mitochondrial ROS with antimycin A will increase telomeric entropic disorder, measurable as reduced circular dichroism signal intensity, preceding detectable telomere length loss.
3. Cells expressing a telomere‑targeted fluorescent G‑quadruplex coherence sensor will show a rapid fluorescence‑lifetime shift when exposed to low‑dose H₂O₂, correlating with early p21 upregulation.
4. Knock‑down of SIRT6, a chromatin modulator that buffers oxidative entropy, will lower the ROS threshold required for coherence collapse and senescence.

Experimental Design

• Cell model: Primary human fibroblasts (low passage) and non‑dividing neurons derived from iPSCs.
• Treatments: (a) ROS generators (antimycin A, H₂O₂), (b) G‑quadruplex stabilizer (pyridostatin), (c) G‑quadruplex destabilizer (telomestatin), (d) SIRT6 siRNA.
• Readouts:
  • Circular dichroism spectra of isolated telomeric DNA to quantify coherence.
  • Telomere‑specific methylation via bisulfite‑seq (subtelomeric regions).
  • Telomere length by qPCR and Teloseq to confirm independence from division count [Telo-seq reveals chromosome‑arm specific rates].
  • Senescence markers (SA‑β‑gal, p16, p21).
  • Mitochondrial ROS (MitoSOX).
• Analysis: Compare coherence loss timing relative to methylation shifts and senescence onset across conditions; use linear mixed models to test interaction between ROS levels and G‑quadruplex ligand presence.

Falsifiability

If G‑quadruplex coherence remains unchanged despite ROS elevation, or if senescence occurs without measurable coherence loss, the hypothesis is refuted. Conversely, demonstrating that coherence preservation uncouples ROS from epigenetic drift and senescence would support the quantum entropy‑sensor model of telomere function.